These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14586145)

  • 1. Ifosfamide in the treatment of head and neck cancer.
    Airoldi M; Cortesina G; Giordano C; Pedani F; Bumma C
    Oncology; 2003; 65 Suppl 2():37-43. PubMed ID: 14586145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction chemotherapy with cisplatin and ifosfamide in locally advanced inoperable squamous cell carcinoma of the head and neck: A single-institution experience.
    Zaheer S; Siddiqui SA; Akram M; Hasan SA
    Indian J Cancer; 2016; 53(3):372-376. PubMed ID: 28244461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.
    Sasaki Y; Kjellén E; Ekblad L; Wahlberg P; Mineta H; Wennerberg J
    Oral Oncol; 2012 Jan; 48(1):61-6. PubMed ID: 21963040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck: a phase I-II study.
    Recchia F; Lalli A; Lombardo M; De Filippis S; Saggio G; Fabbri F; Rosselli M; Capomolla E; Rea S
    Cancer; 2001 Aug; 92(4):814-21. PubMed ID: 11550152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
    J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy with ifosfamide and cisplatin combination in advanced head and neck cancer: a retrospective analysis of 519 patients: a single institution experience.
    Pai VR; Mazumdar AT; Deshmukh CD; Bakshi AV; Parikh DM; Parikh PM; Mistry RC; Pathak KA
    Med Oncol; 2003; 20(1):1-5. PubMed ID: 12665677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer.
    Forastiere AA; Urba SG
    Semin Oncol; 1995 Jun; 22(3 Suppl 6):24-7. PubMed ID: 7597431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel (Taxol)/ifosfamide-based chemotherapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):36-40. PubMed ID: 10697043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Lippman SM; Ginsberg L; Diaz E; Papadimitrakopoulou V; Feng L; Francisco M; Garden A; Kies MS; Myers J; Clayman G; Hong WK
    Cancer; 2002 Jul; 95(2):322-30. PubMed ID: 12124833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.
    Benner SE; Lippman SM; Huber MH; Hong WK
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):22-5. PubMed ID: 7481857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S
    Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.
    Huber MH; Lippman SM; Benner SE; Shirinian M; Dimery IW; Dunnington JS; Hong WK
    Am J Clin Oncol; 1996 Aug; 19(4):379-82. PubMed ID: 8677909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer.
    Basaran M; Bavbek SE; Güllü I; Demirelli F; Sakar B; Tenekeci N; Altun M; Yalçin S; Onat H
    J Chemother; 2002 Apr; 14(2):207-13. PubMed ID: 12017379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Scandurra G; Scibilia G; Banna GL; D'Agate G; Lipari H; Gieri S; Scollo P
    J Gynecol Oncol; 2015 Apr; 26(2):118-24. PubMed ID: 25686397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab.
    Khawandanah M; Baxley A; Pant S
    J Oncol Pharm Pract; 2015 Jun; 21(3):232-7. PubMed ID: 24627343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of high-dose ifosfamide-related nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotrexate and standard-dose ifosfamide.
    Ferrari S; Zolezzi C; Cesari M; Fasano MC; Lamanna G; Bacci G
    Anticancer Drugs; 1999 Jan; 10(1):25-31. PubMed ID: 10194544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preclinical model for experimental chemotherapy of human head and neck cancer.
    Sommer K; Peters SO; Robins IH; Raap M; Wiedemann GJ; Remmert S; Sieg P; Bittner C; Feyerabend T
    Int J Oncol; 2001 Jun; 18(6):1145-9. PubMed ID: 11351243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.